Home/Filings/4/0001126234-24-000114
4//SEC Filing

Schuchart Aaron 4

Accession 0001126234-24-000114

CIK 0001126234other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 9:31 PM ET

Size

17.8 KB

Accession

0001126234-24-000114

Insider Transaction Report

Form 4
Period: 2024-12-12
Schuchart Aaron
Chief Business Officer
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-12-127,8050 total
    Exercise: $10.13Exp: 2031-05-31Common Stock (7,805 underlying)
  • Disposition to Issuer

    Common Stock

    2024-12-128,1790 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-12-1212,0000 total
    Exercise: $2.84Exp: 2034-03-31Common Stock (12,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-12-1245,0000 total
    Exercise: $9.06Exp: 2030-05-05Common Stock (45,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-12-1212,0000 total
    Exercise: $3.52Common Stock (12,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-12-1212,0000 total
    Exercise: $10.02Exp: 2032-01-31Common Stock (12,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-12-128,5000 total
    Exercise: $17.35Exp: 2031-01-31Common Stock (8,500 underlying)
Footnotes (3)
  • [F1]Disposed of pursuant to that certain Agreement and Plan of Merger, dated October 22, 2024, by and between the Issuer, DPV Parent, Inc., DPV MergerSub, Inc. and Double Point Ventures LLC ("DPV") (the "Merger Agreement") in exchange for (i) $4.25 in cash per share (the "Cash Amount"), plus (ii) one non-transferable contingent value right ("CVR") per share. Each restricted stock unit ("RSU") was cancelled and will receive the Cash Amount plus one CVR per RSU.
  • [F2]This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option.
  • [F3]Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement.

Issuer

LUMOS PHARMA, INC.

CIK 0001126234

Entity typeother

Related Parties

1
  • filerCIK 0001709258

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 9:31 PM ET
Size
17.8 KB